Navigation Links
New Findings Offer Systemic Solutions to Address Non-communicable Diseases (NCDs) in Low- and Middle-income Countries
Date:2/4/2013

, our work paves a way forward to achieve better health outcomes through multisectoral and intersectoralcooperation."

Eduardo Pisani , IFPMA Director General, said, "The research-based pharmaceutical industry commissioned these briefs to generate ideas which we hope will contribute to WHO discussions and provide a path forward where our industry is best prepared to play its part with other stakeholders."

The Johns Hopkins policy briefs can be accessed (http://www.ifpma.org/resources/publications.html).

About IFPMA

--------------------------------------------------

1. Authors include:  Brian White-Guay, Lisa Smith , PrashantYadav, SoerenMattke, Margaret Kruk , Felicia Knaul , Gustavo Nigenda, Sir George Alleyne , and SaniaNishtar. Jeffrey L.Sturchio and Louis Galambos served as editors.

IFPMA represents research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry's 1.3 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.


'/>"/>
SOURCE International Federation of Pharmaceutical Manufacturers and Associations
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Proof of Concept Study Initial Findings
2. French Lifestyle Secret Finally Revealed: Lycotec Publishes Unexpected Findings on Roquefort Cheese
3. ENDECE Neural to Present Findings for Remyelination at 2013 Keystone Symposia on Multiple Sclerosis
4. New Findings Link Telehealth-Enabled Care Coordination with Reduced Mortality for Patients with Congestive Heart Failure
5. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
6. iBio Announces At-the-Market Equity Offering
7. KaloBios Pharmaceuticals Announces Pricing of Initial Public Offering
8. Keryx Biopharmaceuticals Announces Pricing of Public Offering of Common Stock
9. Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock
10. NewLink Genetics Corporation Announces Pricing of Public Offering of Common Stock
11. Contract Research Organisations offer Promise of Innovative, Safe and Effective Drug Development, Says Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 29, 2015  The annual customer satisfaction survey of ... EMR as #1 across all specialties. Every year, ... conducts a poll of EHR users and publishes an ... Praxis EMR topped 348 other systems, ... based criteria used by Black Book. In addition to ...
(Date:5/29/2015)... 2015 /CNW/ - Covalon Technologies Ltd. (the "Company" or ... is delighted to announce its financial results for ... includes revenue for three months of $2,180,276 and ... advanced wound care product sales for the three ... to $1,742,672 compared to $1,400,065 for the same ...
(Date:5/29/2015)... 2015 Amgen (NASDAQ: AMGN ) ... 3, global, randomized, placebo-controlled trials evaluating AMG 416, ... hyperparathyroidism (SHPT) in patients with chronic kidney disease ... endpoint, demonstrating that a greater proportion of patients ... than 30 percent reduction in parathyroid hormone (PTH) ...
Breaking Medicine Technology:Praxis EMR Ranks #1 for Physician Satisfaction in Black Book's 2015 Survey of Solo and Small Practices 2Covalon Announces Strong Second Quarter Results 2Covalon Announces Strong Second Quarter Results 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 4Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 6Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 7
(Date:5/29/2015)... Abington Hospital – Jefferson Health ... hospitals in the nation to join the ... and work toward achieving the Baby-Friendly USA© designation. ... on maternity care practices leading to Baby-Friendly designation. ... Prevention, EMPower is aimed at increasing breastfeeding rates ...
(Date:5/29/2015)... On May 21, 2015, Elle Magazine in article titled ... Botox ?” reported on the four most commonly searched beauty ... to determine these results and then sought expert help to ... example, is how to keep neck skin tight . ... the appropriate age to start receiving Botox injections . ...
(Date:5/29/2015)... The Healthcare Delivery Institute at HORNE ... Training Program (ATP) in Healthcare Delivery Improvement. The ... health care organization ranging from clinicians to CFOs, ... quality improvement in the health care environment. The ... internationally recognized Advanced Training Program at Intermountain Healthcare. ...
(Date:5/29/2015)... 29, 2015 The print component of ... circulation of approximately 250,000 and an estimated readership of ... vast social media strategy, and across a network of ... digital version of the campaign, click here. ... publication. Inside, the actress, model and producer details her ...
(Date:5/29/2015)... Shaila Jiwa, a physiotherapist from Burnaby ... stated in a new announcement that patients of urinary ... commonly seen as a tabooed topic to talk about ... like Shaila Jiwa try to encourage people to come ... is a condition that can be classified under two ...
Breaking Medicine News(10 mins):Health News:Abington Hospital Selected to Join Baby-Friendly Hospital Initiative 2Health News:Botox, Wrinkles and Double Chins: The Most-Asked Beauty Problems According to Google 2Health News:HORNE LLP’s Healthcare Delivery Institute Graduates Class from the Advanced Training Program 2Health News:Patients of Urinary Incontinence Should Not "Hide And Suffer," States Physiotherapist from Burnaby Physiotherapy Clinic 2
... , CHICAGO, July 16 GoHealthInsurance ... for quality health insurance, through a network of technology-enabled health insurance ... Owens as Senior Vice President. , , ... insurance, health care and financial industries, and has significant expertise in ...
... 16 Immucor, Inc. (Nasdaq: BLUD ), a ... transfusion industry, today announced that Geoffrey S. Crouse has been ... , In this newly created position, ... as well as sales, marketing and customer service. Mr. Crouse ...
... genes alone aren,t destiny, study finds , THURSDAY, July ... problems are influenced by both genetic and environmental factors, ... on genetic and environmental influences on behavior was often ... of psychiatry, psychology, and human and molecular genetics at ...
... , , BATON ROUGE, ... first of four new facilities designed to help the organization boost ... new Red Cross buildings, located in Baton Rouge, LA, Tallahassee, FL, ... by a $25 million gift from the Kuwaiti people through the ...
... Ohio, July 16 Bedford Laboratories(TM), a division of Ben Venue ... USP. This product is AP rated and is equivalent to ... to treat several types of infections caused by susceptible bacteria. , ... http://www.newscom.com/cgi-bin/prnh/20070809/CLTH157LOGO ) , , ...
... spread, CDC says , THURSDAY, July 16 (HealthDay News) ... of infant illness in the United States, could be ... where infections are likely to spread and by the ... A team including scientists from the U.S. Centers for ...
Cached Medicine News:Health News:GoHealthInsurance Announces Appointment of Mike Owens as Senior Vice President 2Health News:Immucor Appoints Chief Operating Officer 2Health News:Teen Behaviors Stem From Genetics, Environment 2Health News:Gulf Coast Residents to Benefit From Gift of Kuwaiti People 2Health News:Bedford Laboratories(TM) to Begin Shipping Ceftriaxone for Injection USP 2Health News:New Insights Could Help Shield Babies From Diarrhea Bug 2
Terumo's Optitorque offers superior torque and precision control. It's patient-friendly, high torque design makes it the catheter of choice for demanding angiography....
Jography angiographic catheter has a new material combination, a patented angled weld, a flat wire braid design with a XXL lumen. It also has an atraumatic soft tip....
Femoral selective catheter. Catheter material used is polyurethane (TRICOR). Guidewire campatibility is 0.038". Packaging 5/Box....
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
Medicine Products: